logo
A Study Has Revealed The Biggest Risk Factors For Getting Early Dementia, And Knowledge Is Power

A Study Has Revealed The Biggest Risk Factors For Getting Early Dementia, And Knowledge Is Power

Yahoo4 hours ago

A recent study by the University of Exeter and Maastricht University published in JAMA Neurology has identified some of the factors that can lead to early cases of dementia ― some of which may surprise you.
The data analyzed the behaviors of over 350,000 participants younger than 65 across the United Kingdom to evaluate young-onset dementia, which occurs before age 65. The researchers found there are 15 common issues that can contribute to the early development of the condition. A few have to do with genetics and other elements outside our control, but many others are modifiable.
The study is meaningful to experts because it 'looks at young-onset dementia risk factors in a way that has only been done in late-onset dementias previously,' according to Dr. Kevin Bickart, an assistant professor in neurology at the University of California Los Angeles Health's David Geffen School of Medicine. The study features 'a very large sample that was prospectively followed from healthy baseline to a dementia diagnosis with lots of data collection.'
Here's what to know:
The biggest risk factors for young-onset dementia:
Related: "This Has Taken Me Years And Years And YEARS To Figure Out": This Woman's Clever Way To Tell If Someone Is Your Real Friend Is Being Called The Most Accurate Thing Ever
Related: 25 Eye-Opening Confessions From A Trauma Therapist That Changed The Way I Think About Mental Health
The large-scale study looked at 39 possible risk factors and determined that 15 of them made the biggest difference when it came to developing dementia before the age of 65. Those include:
Social isolation
Lower formal education
Lower socioeconomic status
Carrying two copies of the APOE gene (a marker that influences Alzheimer's risk)
Vitamin D deficiency
Hearing impairment
Alcohol use disorder
No alcohol use (abstinence)
Depression
High C-reactive protein levels
Lower handgrip strength (physical frailty)
Orthostatic hypotension (a form of low blood pressure)
Stroke
Diabetes
Heart disease
Although some recognized risks are out of many people's control ― like being a carrier of the APOE gene or your socioeconomic status ― others can be managed through lifestyle changes.
What you can do to lower your risk of early-onset dementia.
Overall, the study results are consistent with what medical experts have been advising patients for years.
Dr. Arman Fesharaki-Zadeh, an assistant professor of psychiatry and of neurology at the Yale School of Medicine, recommended three 'lifestyle measures' that folks may want to consider when trying to lower their risk of young-onset dementia ― starting with physical exercise.
'An active daily exercise practice can have far-reaching benefits, which include enhanced neurocognitive function,' Fesharaki-Zadeh said, adding that physical activity can boost neurogenesis (the formation of new neurons and synapses), vasculogenesis (the creation of new blood vessels) while also providing inherent mood benefits.
Next, focus on eating nourishing foods. Fesharaki-Zadeh championed a Mediterranean-based diet, mentioning its well-documented benefits.
'Such dietary practice, which includes food groups such as green leafy vegetables, olive oil, salmon and blueberries, is rich in vitamins, omega-3 fatty acids, as well as antioxidants ― all neuroprotective factors,' he explained.
Fesharaki-Zadeh recommended cognitive, mood and social stimulation to keep your mind sharp.
For cognitive stimulation, this could look like learning a new language or attending a seminar, listening to music or dancing. Basically, anything that engages your mind will help it stay healthy. Mood stimulation, on the other hand, relates to stress reduction practices, 'such as mindfulness and yoga,' Fesharaki-Zadeh said.
As for social stimulation, it's pretty simple: Try to connect with other humans face-to-face and actually talk to them as much as possible. 'In the era of pandemic and now post-pandemic, quality social connections should increasingly be encouraged and practiced,' Fesharaki-Zadeh said.
While these habits don't cover the whole list of dementia risk factors, they are a pretty solid start.This article originally appeared on HuffPost.
Also in Goodful: Therapists Are Revealing The Moments That Made Them Break Their "No Judgment" Rule, And I'm Honestly Speechless
Also in Goodful: 19 "Garbage" Modern Trends People Refuse To Partake In Despite Their Popularity
Also in Goodful: Medical Professionals Are Sharing "Mundane" Things That Actually Make So Many People Sick

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Older people ‘bombarded' with ads for funerals, care homes and mobility aids
Older people ‘bombarded' with ads for funerals, care homes and mobility aids

Yahoo

timean hour ago

  • Yahoo

Older people ‘bombarded' with ads for funerals, care homes and mobility aids

Older people say they are being 'bombarded' by campaigns for funeral services, care homes and mobility aids by 'out-of-touch' mainstream advertising, a study has found. The Advertising Standards Authority (ASA) said more than a third of the UK population (35%) agreed that older people tended to be negatively stereotyped in ads, with other depictions such as forgetfulness, frailty or not being able to use technology also seen as potentially offensive. While not offensive, depictions such as older people always being wealthy or grumpy, or ads that showed them doing extreme and unrealistic activities, were found to be cliched and irritating. Almost half (49%) said ads using humour at the expense of older people were likely to cause offence. Some 44% believed that older people were either underrepresented or not represented at all in ads, particularly in categories like fashion, beauty, technology and household goods. Respondents also raised concerns about how ads were targeted, saying they felt 'bombarded' by promotions for end-of-life services such as funerals or cremations, life insurance and care homes. The ASA's report, based on focus groups and a survey of 4,000 UK adults, said older people were not only living longer but also continuing to lead full, active lives, contributing to workplaces, families, communities and the economy for longer. However, many of those surveyed said that advertising too often painted a 'very different and outdated picture'. The watchdog said ads showing older people as lonely, purposeless or powerless could be harmful – especially for those aged 75 and over, for whom these portrayals reinforced fears about ageing and social isolation. It also flagged beauty ads that suggested ageing must be 'fought' as potentially harmful. In particular, women aged 65 and over recognised the potential for these ads to cause harm to the self-esteem of women of all ages. The ASA said the findings suggested the ad industry may be 'out of touch' with the reality of ageing. Instead, the public wanted advertising to focus on individuals rather than their age, and portray a diverse range of later-life experiences. The ASA said: 'When ads show older people as vibrant, capable and real, they help rewrite the story of ageing and how we perceive older generations. 'Not only this, but older people represent a significant market with substantial spending power, making them a vital audience for brands that want to stay relevant. 'While we're not currently proposing any new rules, we're hoping that by sharing this research, advertisers will understand how some portrayals of older people are landing with the public today – and where there may be unintended consequences.' Kam Atwal, research lead at the ASA, said: 'As a society, we're living longer, richer and more varied lives. 'Our research reveals that some of today's portrayals of older people in advertising are not being received positively, and that the public want ads to better reflect the varied lives older people lead today. 'This is a real opportunity for brands to embrace the true diversity of later life and take a leading role in challenging outdated perceptions.' Harriet Bailiss, co-head of the Age Without Limits campaign, run by the Centre for Ageing Better charity, said: 'We really welcome this excellent report from the ASA. 'We live in a society where ageism is the most common form of discrimination. We should all want that to end and we all have a role to play in making that happen. 'Advertising has such a powerful influence on society and can help bring about that change and be a force for good, as it has already been for changing other outdated perceptions.'

Campaigners make case for assisted dying Bill ahead of crucial Commons vote
Campaigners make case for assisted dying Bill ahead of crucial Commons vote

Yahoo

timean hour ago

  • Yahoo

Campaigners make case for assisted dying Bill ahead of crucial Commons vote

The MP behind the assisted dying Bill will be joined by bereaved and terminally ill people as she makes her case for a change in the law ahead of a crucial vote on Friday. Kim Leadbeater is expected to re-state her argument that dying people must be given choice at the end of their lives, but opponents of her Bill have warned it fails to guarantee protections for society's most vulnerable. Friday will be the first time the Bill has been debated and voted on in its entirety since last year's historic yes vote, when MPs supported the principle of assisted dying for England and Wales by a majority of 55. MPs are entitled to have a free vote on the Bill, meaning they decide according to their conscience rather than along party lines. The relatively narrow majority means every vote will count on Friday, to secure the Bill's passage to the House of Lords for further debate and voting. An an example, the Bill would fall if 28 MPs switched directly from voting yes to no, but only if all other MPs voted exactly the same way as they did in November, including those who abstained. Prime Minister Sir Keir Starmer has indicated he will continue to back the Bill, as he did last year, saying earlier this week that his 'position is long-standing and well-known' on assisted dying. Health Secretary Wes Streeting, while describing Ms Leadbeater's work on the proposed legislation as 'extremely helpful', confirmed in April that he still intended to vote against it. While supporters of the Bill say it is coming back to the Commons with better safeguards after more than 90 hours of parliamentary time spent on it to date, opponents claim the process has been rushed and that changes to the Bill mean it is now weaker than it was when first introduced. Significant changes since it succeeded in the initial vote in Parliament include the replacement of the High Court safeguard with expert panels, and a doubling of the implementation period to a maximum of four years for an assisted dying service to be in place should the Bill pass into law. Academic and disability campaigner Miro Griffiths has sent an open letter to MPs, asking them not to endorse the 'perilous piece of legislation' even if they support assisted dying in principle. He wrote: 'I would ask you to devote your energy to improving ethical and progressive forms of support: blanket suicide prevention, palliative care, and measures that create a more just and inclusive society for disabled people. This is the better way forward.' Baroness Tanni Grey-Thompson, who would have a vote should the Bill make its way to the House of Lords, said: 'We are constantly being told that this Bill is not for disabled people and there will not be coercion. 'Coercion is an absolute reality in today's society, and in every jurisdiction where assisted dying has been brought in, it has expanded either through legislation, the court system or practice. 'It is very easy to see that this route will be suggested to disabled people who will be made to feel a burden.' The Royal College of Psychiatrists (RCPsych) stated last month that it has 'serious concerns' about the safeguarding of people with mental illness and said it cannot support the Bill in its current form. Ahead of Friday's vote, Dr Annabel Price from the college said that as it stands the involvement of psychiatrists in expert panels is 'deeply troubling' as they would not have 'enough space or time to carry out proper, holistic assessments' and warned of the 'risk (of) making irreversible decisions based on treatable suffering'. Countering this, a number of psychiatrists recently expressed their support for the assisted dying Bill, voicing concern and distancing themselves from the opposition stance taken by their professional medical body. Seven RCPsych members, including a former college president and vice-president, wrote to MPs to voice their backing for the Bill, describing it as 'workable, safe and compassionate' with a 'clear and transparent legal framework' they argue is 'far preferable to the unjust status quo, where we know dying people seek to exercise choice at the end of life, but without any upfront safeguards, routine oversight or support from relevant clinicians'. Meanwhile, Dame Esther Rantzen's daughter Rebecca Wilcox said she is 'really hopeful' the Bill can pass the major vote, as she warned against 'scaremongering' by opponents.

Marksans Pharma's UK subsidiary secures approval for Oxybutynin Hydrochloride oral solution
Marksans Pharma's UK subsidiary secures approval for Oxybutynin Hydrochloride oral solution

Business Upturn

time2 hours ago

  • Business Upturn

Marksans Pharma's UK subsidiary secures approval for Oxybutynin Hydrochloride oral solution

By Aditya Bhagchandani Published on June 19, 2025, 09:14 IST Marksans Pharma Limited announced today that its wholly owned UK-based subsidiary, Relonchem Limited, has received Marketing Authorization for Oxybutynin Hydrochloride 2.5mg/5ml Oral Solution from the UK's Medicines & Healthcare Products Regulatory Agency (MHRA). The product, used primarily for treating overactive bladder and urinary incontinence, expands Marksans' offering in the urology therapeutic segment and strengthens its European portfolio. The company, headquartered in Mumbai, manufactures and markets generic pharmaceutical formulations globally, with facilities in India, the US, and the UK—approved by regulatory bodies including the USFDA, UKMHRA, and Australia's TGA. 'This approval further reinforces our commitment to expanding our presence in regulated markets through high-quality generic products,' the company said in a press release. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store